SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-015264
Filing Date
2024-02-20
Accepted
2024-02-20 15:04:36
Documents
17
Period of Report
2024-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200296-8k_bespoke.htm   iXBRL 8-K 25014
2 FORM OF PURCHASE AGREEMENT ea0200296ex10-1_bespoke.htm EX-10.1 52945
3 FORM OF NOTE ea0200296ex10-2_bespoke.htm EX-10.2 26855
4 FORM OF WARRANT ea0200296ex10-3_bespoke.htm EX-10.3 61434
  Complete submission text file 0001213900-24-015264.txt   374385

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bspk-20240220.xsd EX-101.SCH 3036
6 XBRL LABEL FILE bspk-20240220_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bspk-20240220_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0200296-8k_bespoke_htm.xml XML 3284
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 24652789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)